NDAORALTABLET, EXTENDED RELEASEPriority Review
Approved
Aug 2022
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
(an ionotropic glutamate receptor) and a sigma-1 receptor agonist. The mechanism of dextromethorphan in the treatment of MDD is unclear. The mechanism of action of bupropion in the treatment of MDD is unclear; however, it may be related to noradrenergic and/or dopaminergic mechanisms. Bupropion…
Indications (1)
Loss of Exclusivity
LOE Date
Apr 20, 2043
208 months away
Patent Expiry
Apr 20, 2043